These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 32640055)
1. Obesity, menstrual irregularity and polycystic ovary syndrome in young women with type 1 diabetes: A population-based study. Thong EP; Milat F; Joham AE; Mishra GD; Teede H Clin Endocrinol (Oxf); 2020 Nov; 93(5):564-571. PubMed ID: 32640055 [TBL] [Abstract][Full Text] [Related]
2. Associations of childhood adiposity with menstrual irregularity and polycystic ovary syndrome in adulthood: the Childhood Determinants of Adult Health Study and the Bogalusa Heart Study. He Y; Tian J; Blizzard L; Oddy WH; Dwyer T; Bazzano LA; Hickey M; Harville EW; Venn AJ Hum Reprod; 2020 May; 35(5):1185-1198. PubMed ID: 32344436 [TBL] [Abstract][Full Text] [Related]
3. Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study. West S; Lashen H; Bloigu A; Franks S; Puukka K; Ruokonen A; Järvelin MR; Tapanainen JS; Morin-Papunen L Hum Reprod; 2014 Oct; 29(10):2339-51. PubMed ID: 25085801 [TBL] [Abstract][Full Text] [Related]
4. The contribution of diet, physical activity and sedentary behaviour to body mass index in women with and without polycystic ovary syndrome. Moran LJ; Ranasinha S; Zoungas S; McNaughton SA; Brown WJ; Teede HJ Hum Reprod; 2013 Aug; 28(8):2276-83. PubMed ID: 23771201 [TBL] [Abstract][Full Text] [Related]
6. The Impact of Obesity on the Incidence of Type 2 Diabetes Among Women With Polycystic Ovary Syndrome. Kakoly NS; Earnest A; Teede HJ; Moran LJ; Joham AE Diabetes Care; 2019 Apr; 42(4):560-567. PubMed ID: 30705063 [TBL] [Abstract][Full Text] [Related]
7. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome. Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233 [TBL] [Abstract][Full Text] [Related]
8. Menstrual irregularity and poly cystic ovarian syndrome among adolescent girls--a 2 year follow-up study. Nair MK; Pappachan P; Balakrishnan S; Leena ML; George B; Russell PS Indian J Pediatr; 2012 Jan; 79 Suppl 1():S69-73. PubMed ID: 21769526 [TBL] [Abstract][Full Text] [Related]
9. Prospective associations between physical activity and BMI with irregular periods and heavy menstrual bleeding in a large cohort of Australian women. Mena GP; Mielke GI; Brown WJ Hum Reprod; 2021 May; 36(6):1481-1491. PubMed ID: 33846724 [TBL] [Abstract][Full Text] [Related]
10. Asthma in reproductive-aged women with polycystic ovary syndrome and association with obesity. Htet TD; Teede HJ; de Courten B; Loxton D; Real FG; Moran LJ; Joham AE Eur Respir J; 2017 May; 49(5):. PubMed ID: 28461287 [TBL] [Abstract][Full Text] [Related]
12. Risk of type 2 diabetes mellitus in polycystic ovary syndrome is associated with obesity: a meta-analysis of observational studies. Anagnostis P; Paparodis RD; Bosdou JK; Bothou C; Macut D; Goulis DG; Livadas S Endocrine; 2021 Nov; 74(2):245-253. PubMed ID: 34176074 [TBL] [Abstract][Full Text] [Related]
13. Effect of Dietary Weight Loss on Menstrual Regularity in Obese Young Adult Women with Polycystic Ovary Syndrome. Marzouk TM; Sayed Ahmed WA J Pediatr Adolesc Gynecol; 2015 Dec; 28(6):457-61. PubMed ID: 26298524 [TBL] [Abstract][Full Text] [Related]
14. Reproductive health, obesity, and cardiometabolic risk factors among Samoan women. Maredia H; Hawley NL; Lambert-Messerlian G; Fidow U; Reupena MS; Naseri T; McGarvey ST Am J Hum Biol; 2018 May; 30(3):e23106. PubMed ID: 29663637 [TBL] [Abstract][Full Text] [Related]
15. Effect of visceral manipulation on menstrual complaints in women with polycystic ovarian syndrome. Yosri MM; Hamada HA; Yousef AM J Osteopath Med; 2022 May; 122(8):411-422. PubMed ID: 35488711 [TBL] [Abstract][Full Text] [Related]
16. Effects of Bariatric Surgery on People with Obesity and Polycystic Ovary Syndrome: a Large Single Center Study from India. Bhandari M; Kosta S; Bhandari M; Reddy M; Mathur W; Gupta M Obes Surg; 2022 Oct; 32(10):3305-3312. PubMed ID: 35882755 [TBL] [Abstract][Full Text] [Related]
17. Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome. Ujvari D; Hulchiy M; Calaby A; Nybacka Å; Byström B; Hirschberg AL Hum Reprod; 2014 Jul; 29(7):1526-35. PubMed ID: 24842895 [TBL] [Abstract][Full Text] [Related]
18. Obesity, rather than menstrual cycle pattern or follicle cohort size, determines hyperinsulinaemia, dyslipidaemia and hypertension in ageing women with polycystic ovary syndrome. Elting MW; Korsen TJ; Schoemaker J Clin Endocrinol (Oxf); 2001 Dec; 55(6):767-76. PubMed ID: 11895219 [TBL] [Abstract][Full Text] [Related]
19. Incidence and Predictors of Hypertension in a Cohort of Australian Women With and Without Polycystic Ovary Syndrome. Joham AE; Kakoly NS; Teede HJ; Earnest A J Clin Endocrinol Metab; 2021 May; 106(6):1585-1593. PubMed ID: 33693653 [TBL] [Abstract][Full Text] [Related]
20. Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women. Teede HJ; Joham AE; Paul E; Moran LJ; Loxton D; Jolley D; Lombard C Obesity (Silver Spring); 2013 Aug; 21(8):1526-32. PubMed ID: 23818329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]